Skip to content
Agentic OS
Menu

Intelligence / Healthtech & medtech market map / Medical devices / Surgical and interventional devices

SubmarketREVIEWEDResearched 14 Nov 2026 · refreshed weekly

Surgical and interventional devices

Devices used in operating rooms, catheterisation laboratories, endoscopy, interventional radiology and minimally invasive procedures. Includes robotic, electrophysiology, structural heart, orthopaedic and general surgical devices and their consumables.

Market size
$193B
$193B ($180B–$198B) · 2026 · Top-down
Growth
+6.3%
$336B by 2035
Attractiveness
— /100
for B2B sellers
Evidence
Medium confidence
3 sources · Top-down
Level
Submarket
Segmented by
Use case
Buyers
Hospitals, ambulatory surgery centres, physician practices
Buying centre
Clinical department heads, surgeons, interventional specialists, procurement, value analysis, finance, regulatory affairs
Maturity
Growth
Structure
Fragmented
Buying triggers
  • Approval of new robotic, interventional or implant technologies
  • Opening or expansion of ambulatory surgical centers [6]
  • Hospital procedure-volume growth
  • Replacement of aging systems and renewed capital budgets
Pains
  • Buyers face difficult utilization and return-on-investment cases for high-cost systems
  • Clinical workflow, training and operating-room integration create adoption barriers
  • Sterility, reliability and procedural performance are critical buying criteria
  • Differences in surgical specialties and hospital protocols complicate product standardization
Scores (1–5)
Pain intensity—
Purchasing power—
Reachability—
Growth—
Growth drivers
  • Hospitals and ambulatory surgical centers buy robotic, interventional, orthopaedic and general surgical systems with associated consumables.
  • Aging populations and higher procedure volumes support system utilization and recurring consumable demand [6][7].
  • Cardiovascular intervention and other higher-growth categories are attracting strategic capital [8][10].
  • Minimally invasive procedures create demand for specialized devices and disposables.
Headwinds
  • High acquisition costs constrain hospital capital budgets.
  • Reimbursement and procedure-payment changes can affect adoption [7].
  • Tighter regulatory requirements raise launch and clinical-evidence costs [7].
  • Pricing pressure and tariffs constrain margins and vendor economics [7].
Trends
  • Surgical, endoscopy and robotic systems account for 31% of global device revenue, the largest device-type grouping [6].
  • Robotic, electrophysiology and structural-heart systems support migration toward minimally invasive treatment.
  • The shift of procedures to ambulatory surgical centers changes purchasing channels [6].
  • Procedure-linked consumables create recurring revenue as installed systems are used.

Niches 5

Split by customer type.

Niche70/100

Ambulatory surgery centre and outpatient procedure-device buyers

Same surgical, endoscopy and interventional device families bought by freestanding ambulatory surgery centres, outpatient endoscopy suites and office-based labs rather than by hosp

—
Ambulatory surgery centres, outpatient endoscopy centres, office-based labs and physician practice ASCs
not sizedOpen
Niche80/100

Hospital operating-room surgical and interventional device suites

Devices and consumables bought by hospital OR/cath-lab/endoscopy departments for open and minimally invasive procedures: surgical instruments, energy devices, staplers, sutures, im

—
Hospitals (tertiary and community hospital OR, cath lab, endoscopy, IR and EP departments)
not sizedOpen
Niche60/100

Physician practice and office-based procedure buyers

Devices and consumables purchased by independent physician practices, physician-owned ASCs and office-based labs for in-office and outpatient procedures, including endoscopy, minor

—
Independent physician practices, physician-owned ASCs and office-based labs
not sizedOpen

Companies in this market 8

Named in public sources; linked to the source.

How this was sized

$193B ($180B–$198B) · 2026 · Top-down

Source [6] assigns 31% of global medical-device revenue to surgical, endoscopy and robotic systems. Arithmetic: $623.37bn x 31% = $193.245bn in 2026. The low and high estimates apply the same share to the $580bn and $640bn sector ranges from [4]. Forecast assumes the share remains constant: $193.245bn x 1.0634^9 = $336.030bn in 2035.

Alongside it in Medical devices

// Sell into Surgical and interventional devices

AOS finds the biggest accounts in this submarket with a reason to talk now, maps their buying centre and prepares the outreach for your approval.